What homoeopathy has to offer in the rare disease scenario of India: an overview
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20250949Keywords:
Rare disease, Homoeopathy, Hemophilia, Thalassemia, Sickle cell anemiaAbstract
Incidences of rare diseases (RDs) are subsequently increasing in India. The cost of the treatment involved is exorbitant and therefore it becomes difficult for the patient to afford it. So, the need of the hour is to implement health care policies that are in favor of both, the patients and the government. Keeping in mind the current scenario of the RDs in India this article is written to mitigate this problem as far as possible using the homoeopathic system of medicine. This article delineates a newer approach to RD treatment programs available. Homoeopathy in haemophilia (HIH) research center established in the year 2007, had provided homoeopathic treatment to more than 1300 people with haemophilia i.e. 5.27% according to the annual global survey 2021, where the total number of registered haemophilia patients in India were 25384. Homoeopathy had proven over the years that it works by interacting with the genetic code of the patient. Also, it is based on the principles of symptom similarity rather than disease diagnosis. This makes it more applicable for patients of RDs because it relieves the symptoms and reduces their severity until the proper diagnosis and treatment are provided. Homoeopathy had proved itself to be a cost-beneficial therapy for patients with hemophilia and so this could be the pilot study for the other genetic diseases too.
Metrics
References
Rajasimha HK, Shirol PB, Ramamoorthy P, Hegde M, Barde S, Chandru V, et al. Organization for rare diseases India (ORDI)-Addressing the challenges and opportunities for the Indian rare diseases' community. Genetics Res. 2014;96:e009. DOI: https://doi.org/10.1017/S0016672314000111
Khosla N, Valdez R. A compilation of national plans, policies and government actions for rare diseases in 23 countries. Intractable Rare Dis Res. 2018;7(4):213-22. DOI: https://doi.org/10.5582/irdr.2018.01085
Katoch VM, Majumder PP, Bhattacharya A. Rare diseases need our attention. Curr Sci. 2016;111(1):7-8.
Gahl WA, Markello TC, Toro C, Fajardo KF, Sincan M, Gill F, et al. The national institutes of health undiagnosed diseases program: insights into rare diseases. Genet Med. 2012;14(1):51-9. DOI: https://doi.org/10.1038/gim.0b013e318232a005
Taneja A, Shashidhara LS, Bhattacharya A. Rare diseases in India: Time for cure-driven policy initiatives and action. Curr Sci. 2020;118:1500-6. DOI: https://doi.org/10.18520/cs/v118/i10/1500-1506
Pingali V, Das N. Rare diseases require support too. Vikalpa. 2021;46(2):129-34. DOI: https://doi.org/10.1177/02560909211024554
Katoch VM, Kabra M, Bhattacharya A. Policy towards finding cure and management of rare diseases. Jawaharlal Nehru University and World without GNE Myopathy (India), Recommendations. 2017;3-19.
Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Euro J Human Genet. 2020;28(2):165-73. DOI: https://doi.org/10.1038/s41431-019-0508-0
Bhattacharya SU, Katoch VM, Majumder PP, Bhattacharya AL. Rare diseases in India: current knowledge and new possibilities. InProc Indian Natl Sci Acad. 2016;82(4):1183-7. DOI: https://doi.org/10.16943/ptinsa/2016/48575
Sukumaran A. Am I going to live? Genetic diseases leave 70 million Indians at God’s mercy. Outlook Magazine. 2019;1-6.
Nair KS, Raj S, Tiwari VK, Piang LK. Cost of treatment for cancer: experiences of patients in public hospitals in India. Asian Pacific J Cancer Prevent. 2013;14(9):5049-54. DOI: https://doi.org/10.7314/APJCP.2013.14.9.5049
Yates N. I have spinal muscular atrophy. Critics of the $2 million new gene therapy are missing the point. 2019. Available at: https://www.statnews.com/2019/05/31/spinal-muscular-atrophy-zolgensmaprice-critics/. Accessed on 10 December 2024.
Canadian Agency for Drugs and Technologies in Health, Pharmacoeconomic Review Report on Migalastat (Galafold). CommonDrug Review Rep. 2018;1-30.
Kay PH, Khuda Bukhsh AR. The contribution of homeogenomic and homeogenetic studies in the support of the practice of Homoeopathy. Indian J Res Homoeopathy. 2016;10(2):101-7. DOI: https://doi.org/10.4103/0974-7168.183858
Ghosh K, Ghosh K. Overcoming the challenges of treating hemophilia in resource-limited nations: a focus on medication access and adherence. Expert Rev Hematol. 2021;14(8):721-30. DOI: https://doi.org/10.1080/17474086.2021.1957826
Rajasimha HK. Uniting and connecting >70 M patients with rare diseases in India with global initiatives. Organization for RareDiseases India and International Rare Diseases Research Consortium. 2017. Available at: https://ordindia.org/wp-content/uploads/2017/03/ORDI-IRDiRC-Conf-Paris-Feb2017.pdf. Accessed on 10 December 2024.
Theodorou DJ, Theodorou SJ, Kakitsubata Y. Skeletal muscle disease: patterns of MRI appearances. Brit J Radiol. 2012;85(1020):e1298-308. DOI: https://doi.org/10.1259/bjr/14063641
Kar A, Phadnis S, Dharmarajan S, Nakade J. Epidemiology and social costs of haemophilia in India. Indian J Med Res. 2014;140(1):19.
Kar A, Mirkazemi R, Singh P, Potnis‐Lele M, Lohade S, Lalwani A, et al. Disability in Indian patients with haemophilia. Haemophilia. 2007;13(4):398-404. DOI: https://doi.org/10.1111/j.1365-2516.2007.01483.x
MHRD, Educational statistics at a glance. Ministry of Human Resource Development. GoI. 2018. Available at: https://mhrd.gov.in/sites/upload_files/mhrd/files/statistics-new/ESAG-2018.pdf. Accessed on 10 December 2024.
Dharmarajan S, Gund P, Phadnis S, Lohade S, Lalwani A, Kar A. Treatment decisions and usage of clotting factor concentrate by a cohort of Indian haemophilia patients. Haemophilia. 2011;18(1):e27-9. DOI: https://doi.org/10.1111/j.1365-2516.2011.02668.x
Evans WR, Rafi I. Rare diseases in general practice: recognising the zebras among the horses. Brit J General Pract. 2016;66(652):550-1. DOI: https://doi.org/10.3399/bjgp16X687625
Kundu T, Kumat O, Mirza G, Motiwala F. Episode of Epistaxis in Glanzmann's thrombasthenia. National J Homoeopathy. 2020;22(4):62-5.
Omkar K, Tapas K, Kanjaksha G, Gulfisha M, Rita K. Homeopathic management of afibrinogenemia along with beta‑thalassemia. AYUHOM. 2022;9:46-50. DOI: https://doi.org/10.4103/AYUHOM.AYUHOM_27_22
Kundu T, Kumat O, Mirza G, Kundu R, Singh, T. Homoeopathic Management of Chronic Pediatric Idiopathic Thrombocytopenic Purpura: Case series. Int J Res. 2022;10(11):202-12. DOI: https://doi.org/10.29121/granthaalayah.v10.i11.2022.4898
Kundu T, Shaikh A, Afzal K, Aparna N, Ranjana K, Sudhir K, et al. Homoeopathic medicines substantially reduces the need of clotting factor concentrate in haemophilia patients: results of a blinded placebo controlled cross over trial. Homeopathy. 2012;101:38e43:2011. DOI: https://doi.org/10.1016/j.homp.2011.10.004
Kundu T, Shaik T, Singh P, Sheikh A, Kumat O. Management of Acute Bleeding in Severe Haemophilia Using Homeopathic Medicines: a Multicentric Case Series. J Homeop Ayurv Med. 2015;4:180.
Kundu TK, Barde PB, Jindal GD, Motiwala FF. An Exploratory Study of Autonomic Function Investigations in Hemophiliacs on Homoeopathy Medications Using Impedance Plethysmography. J Evid Based Complementary Altern Med. 2017;22(4):760. DOI: https://doi.org/10.1177/2156587217718750
Kundu T, Ghosh K, Shaikh A, Singh P, Sheikh A, Shah H, et al. Homeopathic Medicine reduces pain and Haemarthrosis in moderate and severe Haemophilia: A multi- centric study. Complement Med Res. 2018;25(5):306-12. DOI: https://doi.org/10.1159/000486557
Kundu T, Kumat O, Mirza G. Add on homoeopathic management of a scrotal hematocele in a diagnosed severe haemophilia patient: Evidence based case report. Int J Homoeopathic Sci. 2020;4(4):19-22. DOI: https://doi.org/10.33545/26164485.2020.v4.i4a.246
Kumat O, Kalda P, Kundu T, Binaykiya S, Kundu R. Significance of Individualised Homoeopathic Medicine in a case of Non-Healing Scalp Wound along with standard management in Moderate Haemophilia B Patient: A Case Report. Int J Creative Res Thoughts. 2022;10(6):f697-700.
Shah H, Kundu T, Shaikh A. Homoeopathic Management of A Case Of Severe Haemophilia Type A With Inhibitor Positive: Case Report. Homoeopathic Links. 2020;33(4):302-8. DOI: https://doi.org/10.1055/s-0040-1718775
Kundu R, Shaikh A, Kundu T, Mirza G, Kumat O, Ghosh K. Substantial reduction of cost of care of PWH by add on homoeopathic medicine reduced the parental anxiety and stress. Int J Hom Sci 2021;5(1):401-5. DOI: https://doi.org/10.33545/26164485.2021.v5.i1g.343
Singh P, Mukherjee K. Cost-benefit analysis and assessment of quality of care in patients with hemophilia undergoing treatment at National Rural Health Mission in Maharashtra, India. Value Heal Regional Issues. 2017;12:101-6. DOI: https://doi.org/10.1016/j.vhri.2016.11.003
Omkar K, Kundu T, Kanjaksha G, Hiral S, Prapti K, Gulfisha M, et al. Add on Homoeopathy reduced the rate of hemoarthrosis in haemophiliacs which in turn postponed disability and improve quality of life in the age group of 8-20 years: A prospective multicentric study. Haemophilia. 2023;29(2):306-12.
Kumat O, Kundu R, Rajput P, Kundu TK, Mirza G, Shaikh A, et al. A review of usage of Telemedicine for Management of Acute Bleeding Episodes in Haemophilia. Int J Hom Sci 2021;5(4):383-387. DOI: https://doi.org/10.33545/26164485.2021.v5.i4f.500
Omkar K, Gulfisha M, Kundu T, Kanjaksha G, Prapti K, Rita K. Add on Homoeopathic medicines alleviated Schizophrenia symptoms in Haemophilia B patient: A Case Report. Int J AYUSH. 2022:11(4);01-10.
Shaikh A, Kundu T, Ghosh K, Kumat O, Mirza G. Factor XIII Deficiency Managed with Individualized Homoeopathic Medicine In Intellectually Disabled Child: An Evidence Based Case Report. Homoeopathic Links. 2022;35(04):307-14. DOI: https://doi.org/10.1055/s-0042-1743479
Jadhav U, Mukherjee K, Thakur H. Usage of complementary and alternative medicine among severe hemophilia A patients in India. J Evidence-Based Complementary Alternative Med. 2013;18(3):191-7. DOI: https://doi.org/10.1177/2156587213484339
Fisher P. What is homeopathy? An introduction. Frontiers in Bioscience-Elite. 2012;4(5):1669-82. DOI: https://doi.org/10.2741/e489
Shah R. Symptom similarity versus disease similarity: revisiting the application of the law of similar and challenging the symptom-centric approach in homeopathy. Homeopathy. 2018;107(03):218-22. DOI: https://doi.org/10.1055/s-0038-1649499
Watson I. A Guide to the Methodologies of Homeopathy. Cutting Edge Publications. 2004.
Aversa R, Petrescu RV, Apicella A, Petrescu FI. About homeopathy or≪ Similia similibuscurentur≫. Am J Engineering Applied Sci. 2016;9(4):1-9. DOI: https://doi.org/10.3844/ajeassp.2016.1062.1087
Bellavite P, Conforti A, Piasere V, Ortolani R. Immunology and homeopathy. Historical background. Evidence-Based Complementary Alternative Med. 2005;2(4):441-52. DOI: https://doi.org/10.1093/ecam/neh141
Walach HA. Entanglement model of homeopathy as an example of generalized entanglement predicted by weak quantum theory. Complementary Med Res. 2003;10(4):192-200. DOI: https://doi.org/10.1159/000073475
Teixeira MZ. Homeopathy: a preventive approach to medicine? Int J High Dilution Res. 2009;8(29):155-72. DOI: https://doi.org/10.51910/ijhdr.v8i29.360
Bastide M. Homoeopathy: a communication process. British Homeopathic J. 1996;85(03):129-30. DOI: https://doi.org/10.1016/S0007-0785(96)80113-X
Chaudhary A, Khurana A. A review on the role of Homoeopathy in epidemics with some reflections on COVID 19 (SARS CoV 2). Indian J Res Homoeopathy. 2020;14(2):100-9. DOI: https://doi.org/10.4103/ijrh.ijrh_34_20
Haehl R. Samuel Hahnemann, his life and work. InSamuel Hahnemann, His Life and Work B. Jain Publishers; 1983.
Haehl R. Samuel Hahnemann: His Life and Work: Based on Recently Discovered State Papers, Documents, Letters, Etc. B. Jain Publishers. 2001.
Hahnemann S. Organon of medicine. 6thedn. New Delhi: B. Jain Publication, Aphorisms. 1990;80-1.
Kent JT. Lectures on homoeopathic philosophy. B. Jain Publishers; 2003.
Kent JT. The art and science of homeopathic medicine. Courier Corporation. 2002.
Roberts HA. The Principles and Art of Cure by Homoeopathy: A Modern Textbook. B. Jain Publishers; 1997.
Kundu TK, Khuda-Bukhsh AR. Effective management of haemophilia patients with a combined therapy to reduce cost: A new approach. Eur J Biomed Pharmaceut Sci. 2018;5(5):748-51.
Singh V, Raidoo DM, Harries CS. The prevalence, patterns of usage and people's attitude towards complementary and alternative medicine (CAM) among the Indian community in Chatsworth, South Africa. BMC Complementary Alternative Med. 2004;4(1):1-7. DOI: https://doi.org/10.1186/1472-6882-4-3
Roy V, Gupta M, Ghosh RK. Perception, attitude and usage of complementary and alternative medicine among doctors and patients in a tertiary care hospital in India. Indian J Pharmacol. 2015;47(2):137. DOI: https://doi.org/10.4103/0253-7613.153418
Thirthalli J, Zhou L, Kumar K, Gao J, Vaid H, Liu H, et al. Traditional, complementary, and alternative medicine approaches to mental health care and psychological wellbeing in India and China. Lancet Psychiatr. 2016;3(7):660-72. DOI: https://doi.org/10.1016/S2215-0366(16)30025-6
Bhalerao MS, Bolshete PM, Swar BD, Bangera TA, Kolhe VR, Tambe MJ, et al. Use of and satisfaction with complementary and alternative medicine in four chronic diseases: a cross-sectional study from India. National medical journal of India. 2013;26(2):75-7.
DuraiPandian J, Toor G, Arora R, Kaur P, Dheeraj KV, Singh Bhullar R, et al. Complementary and alternative medicine treatments among stroke patients in India. Topics Stroke Rehabilitation. 2012;19(5):384-94. DOI: https://doi.org/10.1310/tsr1905-384
Kumar D, Goel NK, Pandey AK, Sarpal SS. Complementary and alternative medicine use among the cancer patients in Northern India. South Asian J Cancer. 2016;5(01):008-11. DOI: https://doi.org/10.4103/2278-330X.179689